OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Extracellular Vesicles is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Metabolic labelling of a subpopulation of small extracellular vesicles using a fluorescent palmitic acid analogue	1768
Neuropathogenic role of astrocyte‐derived extracellular vesicles in HIV‐associated neurocognitive disorders	375
The immunomodulatory ballet of tumour‐derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD‐L1 pathway in cancer	304
Beyond basic characterization and omics: Immunomodulatory roles of platelet‐derived extracellular vesicles unveiled by functional testing	263
Helminth extracellular vesicles co‐opt host monocytes to drive T cell anergy	250
Arabidopsis Produces Distinct Subpopulations of Extracellular Vesicles That Respond Differentially to Biotic Stress, Altering Growth and Infectivity of a Fungal Pathogen	221
Tumour‐derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8‐mediated creatine import in NPM1‐mutated acute myeloid leukaemia	214
	181
GMP‐Compliant Process for the Manufacturing of an Extracellular Vesicles‐Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial	175
Correction to "DetectEV: a Functional Enzymatic Assay to Assess Integrity and Bioactivity of Extracellular Vesicles"	159
Nanoscopic Profiling of Small Extracellular Vesicles via High‐Speed Atomic Force Microscopy (HS‐AFM) Videography	154
Circulating extracellular vesicles in healthy and pathological pregnancies: A scoping review of methodology, rigour and results	142
Extracellular vesicles as a promising source of lipid biomarkers for breast cancer detection in blood plasma	139
Extracellular vesicles from lung tissue drive bone marrow neutrophil recruitment in inflammation	139
Synthetic biology‐based bacterial extracellular vesicles displaying BMP‐2 and CXCR4 to ameliorate osteoporosis	132
Roles of extracellular vesicles in the aging microenvironment and age‐related diseases	129
A new subtype of artificial cell‐derived vesicles from dental pulp stem cells with the bioequivalence and higher acquisition efficiency compared to extracellular vesicles	126
Glycoengineered extracellular vesicles released from antibacterial hydrogel facilitate diabetic wound healing by promoting angiogenesis	124
Gut Microbiota‐Derived Extracellular Vesicles Influence Alcohol Intake Preferences in Rats	123
	119
Engineering of CD63 Enables Selective Extracellular Vesicle Cargo Loading and Enhanced Payload Delivery	113
Breast Cancer‐Derived Extracellular Vesicles Modulate the Cytoplasmic and Cytoskeletal Dynamics of Blood‐Brain Barrier Endothelial Cells	109
Distinct molecular properties and functions of small EV subpopulations isolated from human umbilical cord MSCs using tangential flow filtration combined with size exclusion chromatography	104
A multiantigenic antibacterial nanovaccine utilizing hybrid membrane vesicles for combating Pseudomonas aeruginosa infections	103
Engineered Cas9 extracellular vesicles as a novel gene editing tool	103

A systematic review and meta‐analysis of clinical trials assessing safety and efficacy of human extracellular vesicle‐based therapy	99
Imaging of surface microdomains on individual extracellular vesicles in 3‐D	99
	98
ISEV2023 Abstract Book	97
Extracellular vesicles and high‐density lipoproteins: Exercise and oestrogen‐responsive small RNA carriers	95
Correction to “Accessory ESCRT‐III proteins are conserved and selective regulators of Rab11a‐exosome formation”	95
TGF‐β regulates the release of breast cancer cell‐derived extracellular vesicles and the sorting of their protein cargo by downregulating RAB27B expression	92
Extracellular vesicle surface display of αPD‐L1 and αCD3 antibodies via engineered late domain‐based scaffold to activate T‐cell anti‐tumor immunity	92
Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How To Account for Histocompatibility and Disease Specificity of EV Treatments	90
	89
	81
Bacterial outer membrane vesicles induce a transcriptional shift in arabidopsis towards immune system activation leading to suppression of pathogen growth in planta	79
	75
Dynamic Change of PD‐L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti‐PD‐1 Therapy	72
Correction to "Microbead Encapsulation Strategy for Efficient Production of Extracellular Vesicles Derived From Human Mesenchymal Stem Cells"	71
USP5‐Rich Apoptotic Extracellular Vesicles Regulate Nucleus Pulposus Cells Apoptosis and DNA Damage Repair by Preventing E2F1 Proteasomal Degradation	70
Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles	68
Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models	67
Phloem sap from melon plants contains extracellular vesicles that carry active proteasomes which increase in response to aphid infestation	66
A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants	66
MIBlood‐EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research	63
Neddylation of Coro1a determines the fate of multivesicular bodies and biogenesis of extracellular vesicles	62
Hyaluronic acid: An overlooked extracellular vesicle contaminant	61
	60
	60
Extracellular Vesicles From Xylella fastidiosa Carry sRNAs and Genomic Islands, Suggesting Roles in Recipient Cells	59
The Procoagulant and Fibrinolytic Balance of Extracellular Vesicles Predicts Mortality in Septic Shock Patients	59
Hypoxia and TNF‐alpha modulate extracellular vesicle release from human induced pluripotent stem cell‐derived cardiomyocytes	58
Circulating Extracellular Vesicles as Putative Mediators of Cardiovascular Disease in Paediatric Chronic Kidney Disease	57
Corrigendum	57
Homosalate boosts the release of tumour‐derived extracellular vesicles with protection against anchorage‐loss property	56
Cell‐engineered virus‐mimetic nanovesicles for vaccination against enveloped viruses	56
Quantitative imaging of vesicle–protein interactions reveals close cooperation among proteins	56